Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening
Phase 3
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Adrenal Gland Diseases, Adrenal Gland Neoplasms
Both
Adrenal Gland Diseases, Adrenal Gland Neoplasms
Trial Information
Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening
Inclusion Criteria
Adults with suspected adrenal disease, such as adrenal adenoma, carcinoma, hyperplasia, or
Addison's Disease.
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Principal Investigator
Donald A. Podoloff, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
M.D. Anderson Cancer Center
Authority:
United States: Food and Drug Administration
Study ID:
NUM88-001
NCT ID:
NCT00037843
Start Date:
December 1988
Completion Date:
August 2007
Related Keywords:
- Adrenal Gland Diseases
- Adrenal Gland Neoplasms
- adrenal diseases
- Adrenal Gland Diseases
- Adrenal Gland Neoplasms
- Neoplasms
Name | Location |
|---|---|
| University of Texas M.D. Anderson Cancer Center | Houston, Texas 77030 |
